ADMA BioCenters Plasma Collection Facility coming to Knoxville, TN

Many rare, chronic conditions with no known cures, including alpha-1 antitrypsin deficiency, can be managed with augmentation therapy treatments made from donated plasma.

States with regulations exceeding FDA standards create barriers for plasma centers, donors, and patients.

While tetanus and rabies are fairly rare in the United States today, these deadly diseases still pose a major global health threat. However, plasma-derived antibody products play a crucial role in treating these illnesses around the world.

Members of the congressional Plasma Caucus provide a venue to educate legislators on important legislation to provide access to patients who rely on immunoglobulin (Ig) therapy.

The need for plasma is forecasted to increase since more patients are being diagnosed with current and newly discovered rare conditions as well as additional indications being approved for plasma medications.

Misconceptions about plasma donation, such as that it is bad for your health, lead to undue misapprehensions.